Secukinumab trials for Psoriasis

All Secukinumab trials · All Psoriasis trials

Phase breakdown

Recruiting trials studying Secukinumab for Psoriasis

• Evaluating the Role of IL-17 as an Orchestrator of Peripheral-central Cross Talk in Depressive Symptoms
  NCT06786936 · Phase: Not specified · Ages: 18 Years to 74 Years · Sex: All (male and female) · 2 locations
• Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
  NCT07138898 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Regulatory Post-Marketing Surveillance in Hidradenitis Suppurativa, Pediatric Plaque Psoriasis and JIA Treated With Cosentyx®(Secukinumab) in Korea
  NCT07243782 · Phase: Not specified · Ages: 6 Years to 100 Years · Sex: All (male and female) · 1 location

Common questions

How many trials study Secukinumab for Psoriasis?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.